Sana Biotechnology (SANA) Short Interest Ratio & Short Volume → What is Nvidia’s New $1 Trillion Superproject? (From Weiss Ratings) (Ad) Free SANA Stock Alerts $7.98 -0.28 (-3.39%) (As of 04:29 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Sana Biotechnology Short Interest DataCurrent Short Interest25,650,000 sharesPrevious Short Interest26,720,000 sharesChange Vs. Previous Month-4.00%Dollar Volume Sold Short$230.85 millionShort Interest Ratio12.5 Days to CoverLast Record DateApril 30, 2024Outstanding Shares221,500,000 sharesFloat Size123,020,000 sharesShort Percent of Float20.85%Today's Trading Volume1,691,567 sharesAverage Trading Volume2,811,877 sharesToday's Volume Vs. Average60% Short Selling Sana Biotechnology ? Sign up to receive the latest short interest report for Sana Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSANA Short Interest Over TimeSANA Days to Cover Over TimeSANA Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Sana Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202425,650,000 shares $230.85 million -4.0%20.9%12.5 $9.00 4/15/202426,720,000 shares $228.46 million +2.3%21.8%13.4 $8.55 3/31/202426,130,000 shares $261.30 million +5.9%22.2%7.9 $10.00 3/15/202424,680,000 shares $219.16 million +17.2%20.9%7.3 $8.88 2/29/202421,050,000 shares $211.34 million -4.7%17.9%6.1 $10.04 2/15/202422,080,000 shares $188.12 million +3.1%20.8%6.9 $8.52 Get the Latest News and Ratings for SANA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sana Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 1/31/202421,420,000 shares $117.60 million +6.2%21.5%7.2 $5.49 1/15/202420,170,000 shares $127.68 million -8.5%20.2%7.1 $6.33 12/31/202322,050,000 shares $89.96 million +3.8%22.3%13.8 $4.08 12/15/202321,240,000 shares $85.17 million +2.1%21.4%14.5 $4.01 11/30/202320,810,000 shares $84.49 million -3.7%21.1%15.4 $4.06 11/15/202321,600,000 shares $91.58 million -3.4%21.8%17.1 $4.24 10/31/202322,370,000 shares $66.22 million -13.3%22.8%19.1 $2.96 10/15/202325,800,000 shares $86.43 million +5.5%26.2%23.9 $3.35 9/30/202324,450,000 shares $94.62 million +8.4%24.9%24.5 $3.87 9/15/202322,560,000 shares $100.84 million -3.7%22.9%25 $4.47 8/31/202323,420,000 shares $125.30 million +0.6%26.7%23.9 $5.35 8/15/202323,290,000 shares $125.30 million -0.9%26.6%21.2 $5.38 7/31/202323,490,000 shares $137.65 million -14.4%27.0%18.9 $5.86 7/15/202327,430,000 shares $158.55 million -1.4%32.5%21.1 $5.78 6/30/202327,820,000 shares $165.81 million +1.3%32.9%19.5 $5.96 6/15/202327,470,000 shares $178.56 million -2.9%32.5%18.8 $6.50 5/31/202328,280,000 shares $170.25 million +0.1%33.7%20.8 $6.02 5/15/202328,240,000 shares $212.36 million +0.0%33.8%21.1 $7.52 4/30/202328,230,000 shares $149.34 million -4.5%34.3%24.1 $5.29 4/15/202329,550,000 shares $153.36 million -2.7%35.9%26.2 $5.19 3/31/202330,360,000 shares $99.28 million +1.2%37.0%30.4 $3.27 3/15/202330,010,000 shares $102.63 million +7.8%36.6%30 $3.42 2/28/202327,840,000 shares $102.17 million +3.2%34.1%28.9 $3.67 2/15/202326,980,000 shares $125.19 million +3.8%33.0%28.5 $4.64 1/31/202326,000,000 shares $118.56 million -2.1%31.7%25.7 $4.56 1/15/202326,550,000 shares $125.58 million +3.3%32.4%26 $4.73 12/30/202225,710,000 shares $101.55 million +1.7%31.3%26.2 $3.95 12/15/202225,290,000 shares $98.63 million +2.5%30.8%25.3 $3.90 11/30/202224,680,000 shares $123.15 million -1.0%30.2%23.7 $4.99 11/15/202224,930,000 shares $138.36 million -2.0%30.5%24 $5.55 10/31/202225,440,000 shares $147.55 million +0.7%30.1%22.5 $5.80 10/15/202225,270,000 shares $128.12 million -0.8%30.0%21.4 $5.07 9/30/202225,460,000 shares $152.76 million -1.7%30.2%20.5 $6.00 9/15/202225,910,000 shares $184.74 million +1.7%32.6%18.6 $7.13Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. 8/31/202225,490,000 shares $173.59 million +3.3%32.1%18 $6.81 8/15/202224,680,000 shares $208.30 million +1.9%31.0%16.3 $8.44 7/31/202224,220,000 shares $161.79 million +8.4%30.7%15 $6.68 7/15/202222,350,000 shares $170.08 million +5.7%28.3%14 $7.61 6/30/202221,150,000 shares $135.99 million +11.1%26.8%12.8 $6.43 6/15/202219,030,000 shares $82.59 million +0.5%24.1%11.5 $4.34 5/31/202218,940,000 shares $97.16 million +1.6%24.0%11.8 $5.13 5/15/202218,640,000 shares $93.95 million +3.6%23.6%12.3 $5.04 4/30/202218,000,000 shares $135.90 million +1.4%23.3%13.2 $7.55 4/15/202217,750,000 shares $148.39 million +8.0%22.9%13.2 $8.36 3/31/202216,440,000 shares $135.79 million +20.2%21.4%12.9 $8.26 3/15/202213,680,000 shares $78.52 million +1.5%17.8%12.6 $5.74 2/28/202213,480,000 shares $87.08 million +3.9%17.6%13.8 $6.46 2/15/202212,970,000 shares $92.99 million +15.4%16.9%13.7 $7.17 1/31/202211,240,000 shares $98.46 million +18.6%14.6%13 $8.76 1/15/20229,480,000 shares $107.79 million -3.2%12.4%13.5 $11.37 12/31/20219,790,000 shares $151.55 million +23.6%12.8%16.6 $15.48 12/15/20217,920,000 shares $134.72 million +7.6%10.3%13.5 $17.01 11/30/20217,360,000 shares $139.91 million -7.8%9.7%9.1 $19.01 11/15/20217,980,000 shares $171.17 million -1.9%10.5%9.1 $21.45 10/29/20218,130,000 shares $168.62 million -3.0%10.6%9 $20.74 10/15/20218,380,000 shares $174.22 million -0.4%10.9%9.1 $20.79 9/30/20218,410,000 shares $189.39 million +32.2%11.0%9.4 $22.52 9/15/20216,360,000 shares $164.60 million -2.0%8.3%6.9 $25.88 8/31/20216,490,000 shares $155.76 million +2.2%8.5%10.1 $24.00 8/13/20216,350,000 shares $129.35 million No Change8.3%13.1 $20.37 SANA Short Interest - Frequently Asked Questions What is Sana Biotechnology's current short interest? Short interest is the volume of Sana Biotechnology shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 25,650,000 shares of SANA short. 20.85% of Sana Biotechnology's shares are currently sold short. Learn More on Sana Biotechnology's current short interest. What is a good short interest ratio for Sana Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SANA shares currently have a short interest ratio of 12.0. Learn More on Sana Biotechnology's short interest ratio. What is a good short interest percentage for Sana Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.85% of Sana Biotechnology's floating shares are currently sold short. Is Sana Biotechnology's short interest increasing or decreasing? Sana Biotechnology saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 25,650,000 shares, a drop of 4.0% from the previous total of 26,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sana Biotechnology's float size? Sana Biotechnology currently has issued a total of 221,500,000 shares. Some of Sana Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sana Biotechnology currently has a public float of 123,020,000 shares. How does Sana Biotechnology's short interest compare to its competitors? 20.85% of Sana Biotechnology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Sana Biotechnology: Fusion Pharmaceuticals Inc. (4.64%), Inhibrx, Inc. (4.18%), Harmony Biosciences Holdings, Inc. (16.05%), Veracyte, Inc. (5.74%), Beam Therapeutics Inc. (17.03%), Novavax, Inc. (32.00%), Ginkgo Bioworks Holdings, Inc. (20.84%), Kymera Therapeutics, Inc. (16.15%), Neumora Therapeutics, Inc. (12.27%), ADMA Biologics, Inc. (3.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Sana Biotechnology stock? Short selling SANA is an investing strategy that aims to generate trading profit from Sana Biotechnology as its price is falling. SANA shares are trading down $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sana Biotechnology? A short squeeze for Sana Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SANA, which in turn drives the price of the stock up even further. How often is Sana Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SANA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: FUSN Short Interest INBX Short Interest HRMY Short Interest VCYT Short Interest BEAM Short Interest NVAX Short Interest DNA Short Interest KYMR Short Interest NMRA Short Interest ADMA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SANA) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaThis could mean the end of the U.S dollar…Colonial MetalsThe Presidential candidate you should REALLY be worried aboutStansberry ResearchWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeNew Options need New Trading StrategiesNetpicks